Protocol for a randomized controlled trial to test the acceptability and adherence to 6-months of walnut supplementation in Chinese adults at high risk of cardiovascular disease

Yishu Liu(Peking University), Jason Wu(The George Institute for Global Health), Xiong‐Fei Pan(Sichuan University), Ni Yan(Ningxia Medical University), Maoyi Tian(Harbin Medical University), Renata Micha(Tufts University), Dariush Mozaffarian(Tufts University), Bruce Neal(UNSW Sydney), Yanfang Wang(Peking University), Qiang Li(Fuzhou University), Nan Li(Tianjin University of Traditional Chinese Medicine), Mark D. Huffman(Northwestern University), Yi Zhao(Ningxia Medical University)
Nutrition Journal
January 6, 2021
10.1186/s12937-020-00660-7
Cited by 7

Related Papers

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k